“Expansion of Delivery Technologies and Platform Innovation”
- One prominent trend in the global RNA therapeutics market is the rapid expansion of delivery technologies and innovation in RNA platform
- These Effective delivery remains a critical component for the success of RNA-based therapies, and recent advancements such as lipid nanoparticles (LNPs), exosomes, and polymer-based carriers have significantly improved the stability and targeting of RNA molecules in the body
- For instance, the success of LNPs in delivering mRNA vaccines during the COVID-19 pandemic has paved the way for broader applications of these delivery systems in treating cancer, rare genetic disorders, and infectious diseases
- Platform innovations are also driving the development of next-generation RNA therapies, including self-amplifying RNA (saRNA), circular RNA (circRNA), and RNA editing technologies, which offer enhanced efficacy, reduced dosing frequency, and broader therapeutic potential
- This trend is transforming the RNA therapeutics landscape, accelerating drug development pipelines, and expanding the scope of treatable conditions through RNA-based approaches
